Interleukin-6 as a Prognostic Biomarker in Ruptured Intracranial Aneurysms

Localized Increase of Chemokines in the Lumen of Human Cerebral Aneurysms

(2013) Nohra Chalouhi et al.   STROKE

Inflammation as a predictor for delayed cerebral ischemia after aneurysmal subarachnoid haemorrhage

(2012) Catherine J McMahon et al.   Journal of NeuroInterventional Surgery

Timing of Aneurysm Treatment After Subarachnoid Hemorrhage

(2012) Sanne M. Dorhout Mees et al.   STROKE

Aneurysmal subarachnoid hemorrhage

(2011) Margaret J. Rose   Current Opinion in Anesthesiology

Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2)

(2011) R Loch Macdonald et al.   LANCET NEUROLOGY

Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis

(2011) Monique HM Vlak et al.   LANCET NEUROLOGY

Disappointing results for clazosentan in CONSCIOUS-2

(2011) Philip M. Meyers et al.   Nature Reviews Neurology

Preventing Vasospasm Improves Outcome After Aneurysmal Subarachnoid Hemorrhage: Rationale and Design of CONSCIOUS-2 and CONSCIOUS-3 Trials

(2010) R. Loch Macdonald et al.   Neurocritical Care

Relevance of Cerebral Interleukin-6 After Aneurysmal Subarachnoid Hemorrhage

(2010) Asita Sarrafzadeh et al.   Neurocritical Care

Systematic review of the association between circulating interleukin-6 (IL-6) and cancer

(2008) Katriina Heikkilä et al.   EUROPEAN JOURNAL OF CANCER

The Burden of the Systemic Inflammatory Response Predicts Vasospasm and Outcome after Subarachnoid Hemorrhage

(2008) Rajat Dhar et al.   Neurocritical Care

Clazosentan to Overcome Neurological Ischemia and Infarction Occurring After Subarachnoid Hemorrhage (CONSCIOUS-1)

(2008) R. Loch Macdonald et al.   STROKE